Fraction Unbound for Liver Microsome and Hepatocyte Incubations for All Major Species Can Be Approximated Using a Single-Species Surrogate
- 7 February 2019
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 47 (4), 419-423
- https://doi.org/10.1124/dmd.118.085936
Abstract
It is well-recognized that nonspecific binding of a drug within an in vitro assay (fu) can have a large impact on in vitro to in vivo correlations of intrinsic clearance. Typically, this value is determined experimentally across multiple species in the drug discovery stage. Herein we examine the feasibility of using a single species (rat) as a surrogate for other species using a panel of small molecules representing highly diverse structures and physiochemical classes. The study demonstrated that 86% and 92% of the tested compounds measured in mouse, dog, monkey, and human were within two-fold of rat values for fu in microsomes and hepatocytes, respectively. One compound, amiodarone, exhibited unique species-dependent binding where the fu was approximately 10-fold higher in human microsomes and 20-fold higher in human hepatocytes compared to the average of the other species tested. Overall, these data indicate that using a single species (rat) fu as a surrogate for other major species, including human, is a means to increase the throughput of measuring non-specific binding in vitro.Keywords
This publication has 10 references indexed in Scilit:
- Comparison of Species and Cell-Type Differences in Fraction Unbound of Liver Tissues, Hepatocytes, and Cell LinesDrug Metabolism and Disposition, 2018
- A Fragment-Based Approach for the Computational Prediction of the Nonspecific Binding of Drugs to Hepatic MicrosomesDrug Metabolism and Disposition, 2016
- A general mechanism for drug promiscuity: Studies with amiodarone and other antiarrhythmicsThe Journal of general physiology, 2015
- When is Protein Binding Important?*Journal of Pharmaceutical Sciences, 2013
- Microsome composition-based model as a mechanistic tool to predict nonspecific binding of drugs in liver microsomesJournal of Pharmaceutical Sciences, 2011
- Lack of Appreciable Species Differences in Nonspecific Microsomal BindingJournal of Pharmaceutical Sciences, 2010
- Assessment ofin silicomodels for fraction of unbound drug in human liver microsomesExpert Opinion on Drug Metabolism & Toxicology, 2010
- BINDING OF DRUGS TO HEPATIC MICROSOMES: COMMENT AND ASSESSMENT OF CURRENT PREDICTION METHODOLOGY WITH RECOMMENDATION FOR IMPROVEMENT: Fig. 1.Drug Metabolism and Disposition, 2006
- The Influence of Nonspecific Microsomal Binding on Apparent Intrinsic Clearance, and Its Prediction from Physicochemical PropertiesDrug Metabolism and Disposition, 2002
- Comparison of human and rat liver microsomes by spin label and biochemical analysesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1983